Released: February 12, 2014
Defense Health Program
Department of Defense Peer Reviewed Medical Research Program
Fiscal Year 2014 Appropriation Announcement
The Fiscal Year 2014 (FY14) Defense Appropriations Act provides $200 million to the Department of Defense Peer Reviewed Medical Research Program (PRMRP). The funding is provided to support select medical research projects of clear scientific merit and direct relevance to military health.
Research support is restricted to the following congressionally directed topic areas:
- Chronic Migraine and Posttraumatic Headache
- Congenital Heart Disease
- DNA Vaccine Technology for Postexposure Prophylaxis
- Food Allergies
- Fragile X Syndrome
- Hereditary Angioedema
- Illnesses Related to Radiation Exposure
- Inflammatory Bowel Disease
- Interstitial Cystitis
- Metabolic Disease
- Polycystic Kidney Disease
- Post-Traumatic Osteoarthritis
- Psychotropic Medications
- Respiratory Health
- Rheumatoid Arthritis
- Segmental Bone Defects
The vision of the PRMRP is to improve the health and well-being of all military service members, veterans, and beneficiaries. This program is administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) through the Office of the Congressionally Directed Medical Research Programs (CDMRP).
FY14 PRMRP program announcements and general application instructions are anticipated to be posted on Grants.gov in Spring 2014. Application deadlines will be available when the Program Announcements are released. This press release should not be construed as an obligation by the government.
All applications must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov (https://grants.gov) website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Point of Contact:
- CDMRP Public Affairs